|
⚲
|
| Keyboard |
| Paradigm Biocapital Advisors LP | |
|---|---|
| Firm | |
| Address | 767 Third Avenue 17th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Paradigm Biocapital International Fund Ltd | 021-394407 | Promoter | 696.9 M | ||
| Paradigm Biocapital Partners Fund Ltd | 021-394395 | Promoter | 591.6 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2024-08-01 | Sell | 529,501 | $14.92 | 7,900,155 |
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2024-08-01 | Sell | 1,870,499 | $14.92 | 27,907,845 |
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2023-12-06 | Buy | 100,000 | $11.60 | 1,160,000 |